Federal announces no new J&J vaccine to be issued to the states next week

The Federal Government of the United States will no longer issue Johnson & Johnson vaccine doses to states next week due to the Centers for Disease Control and Prevention (CDC) confirmation regarding the increasing number of cases of rare blood clots in patients who had received J&J shots.

It was formerly believed that the vaccine would prove to be an effective workhouse for protecting the citizens against the global pandemic, but US Federal Officials have said warned the allocations of it to the states would be very few until the U.S. Food and Drug Administration clears a troubled manufacturing plant operated by a Johnson & Johnson.

J&J said that the company would be tackling the outbreak with a non-profitable approach, contrarily corresponding similar companies like are expecting high substantial commercial hopes. With analysts predicting the sales of Pzifer and Moderna in billions of dollars in the coming years.

Thereby, Johnson & Johnson shares were flat in premarket trading on Friday whereas Pfizer shares were up 0.1% and shares of Moderna were up 1.3%.